JP2017501152A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017501152A5 JP2017501152A5 JP2016539182A JP2016539182A JP2017501152A5 JP 2017501152 A5 JP2017501152 A5 JP 2017501152A5 JP 2016539182 A JP2016539182 A JP 2016539182A JP 2016539182 A JP2016539182 A JP 2016539182A JP 2017501152 A5 JP2017501152 A5 JP 2017501152A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- cys
- solution
- radioactive tracer
- thr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 18
- 239000000700 radioactive tracer Substances 0.000 claims 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 12
- 239000000243 solution Substances 0.000 claims 12
- 239000003960 organic solvent Substances 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims 4
- 239000012156 elution solvent Substances 0.000 claims 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- 108090000790 Enzymes Proteins 0.000 claims 3
- 102000004190 Enzymes Human genes 0.000 claims 3
- 239000007864 aqueous solution Substances 0.000 claims 3
- 229940124553 radioprotectant Drugs 0.000 claims 3
- 238000001044 reversed-phase solid-phase extraction Methods 0.000 claims 3
- 238000005406 washing Methods 0.000 claims 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 claims 2
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- 101800005149 Peptide B Proteins 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 150000001768 cations Chemical class 0.000 claims 2
- 238000004140 cleaning Methods 0.000 claims 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 108010091748 peptide A Proteins 0.000 claims 2
- 108010005636 polypeptide C Proteins 0.000 claims 2
- 238000000746 purification Methods 0.000 claims 2
- 239000012217 radiopharmaceutical Substances 0.000 claims 2
- 229940121896 radiopharmaceutical Drugs 0.000 claims 2
- 230000002799 radiopharmaceutical effect Effects 0.000 claims 2
- 230000003537 radioprotector Effects 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- YYLQUHNPNCGKJQ-NHYDCYSISA-N (3R)-3-hydroxy-L-aspartic acid Chemical compound OC(=O)[C@@H](N)[C@@H](O)C(O)=O YYLQUHNPNCGKJQ-NHYDCYSISA-N 0.000 claims 1
- 108010062877 Bacteriocins Proteins 0.000 claims 1
- 108010069514 Cyclic Peptides Proteins 0.000 claims 1
- 102000001189 Cyclic Peptides Human genes 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 239000000556 agonist Substances 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 229960004050 aminobenzoic acid Drugs 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 239000012062 aqueous buffer Substances 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 239000012738 dissolution medium Substances 0.000 claims 1
- 239000002532 enzyme inhibitor Substances 0.000 claims 1
- 229940125532 enzyme inhibitor Drugs 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 229960005219 gentisic acid Drugs 0.000 claims 1
- 239000000718 radiation-protective agent Substances 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1322451.4 | 2013-12-18 | ||
| GBGB1322451.4A GB201322451D0 (en) | 2013-12-18 | 2013-12-18 | Purification method and compositions |
| PCT/EP2014/078608 WO2015091881A1 (en) | 2013-12-18 | 2014-12-18 | Purification method and compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019108641A Division JP2019196356A (ja) | 2013-12-18 | 2019-06-11 | 精製方法及び組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017501152A JP2017501152A (ja) | 2017-01-12 |
| JP2017501152A5 true JP2017501152A5 (enExample) | 2017-12-28 |
| JP6842920B2 JP6842920B2 (ja) | 2021-03-17 |
Family
ID=50071048
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016539182A Active JP6842920B2 (ja) | 2013-12-18 | 2014-12-18 | 精製方法及び組成物 |
| JP2019108641A Withdrawn JP2019196356A (ja) | 2013-12-18 | 2019-06-11 | 精製方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019108641A Withdrawn JP2019196356A (ja) | 2013-12-18 | 2019-06-11 | 精製方法及び組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20160303262A1 (enExample) |
| EP (1) | EP3083526B1 (enExample) |
| JP (2) | JP6842920B2 (enExample) |
| CN (1) | CN105849067B (enExample) |
| ES (1) | ES2750624T3 (enExample) |
| GB (1) | GB201322451D0 (enExample) |
| HK (1) | HK1226050B (enExample) |
| WO (1) | WO2015091881A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120165650A1 (en) * | 2010-12-22 | 2012-06-28 | General Electric Company | Her2 binders |
| GB201314936D0 (en) | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
| GB201322456D0 (en) | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
| US20210350946A1 (en) * | 2019-10-25 | 2021-11-11 | ITM Isotopen Technologien München AG | System and method of recovering a parent radionuclide from a radionuclide generator |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2119458B9 (en) * | 2007-02-13 | 2013-08-21 | Nihon Medi-Physics Co., Ltd. | Method for production of radiation diagnostic imaging agent |
| GB201013808D0 (en) * | 2010-08-18 | 2010-09-29 | Ge Healthcare Ltd | Peptide radiotracer compositions |
| CA2819347A1 (en) * | 2010-12-01 | 2012-06-07 | Ge Healthcare Limited | Radioconjugation method |
| GB201020314D0 (en) * | 2010-12-01 | 2011-01-12 | Ge Healthcare Ltd | Apoptosis pet imaging agents |
| NZ612327A (en) * | 2010-12-22 | 2015-03-27 | Ge Healthcare Ltd | Her2 binding peptides labelled with a 18f - containing organosilicon compound |
| GB201202420D0 (en) * | 2012-02-13 | 2012-03-28 | Ge Healthcare Ltd | Radiotracer compositions |
| GB201209082D0 (en) * | 2012-05-24 | 2012-07-04 | Ge Healthcare Ltd | Purification method |
-
2013
- 2013-12-18 GB GBGB1322451.4A patent/GB201322451D0/en not_active Ceased
-
2014
- 2014-12-18 WO PCT/EP2014/078608 patent/WO2015091881A1/en not_active Ceased
- 2014-12-18 EP EP14815726.6A patent/EP3083526B1/en active Active
- 2014-12-18 JP JP2016539182A patent/JP6842920B2/ja active Active
- 2014-12-18 HK HK16114397.2A patent/HK1226050B/zh unknown
- 2014-12-18 ES ES14815726T patent/ES2750624T3/es active Active
- 2014-12-18 CN CN201480069376.6A patent/CN105849067B/zh active Active
- 2014-12-18 US US15/102,511 patent/US20160303262A1/en not_active Abandoned
-
2019
- 2019-06-11 JP JP2019108641A patent/JP2019196356A/ja not_active Withdrawn
-
2021
- 2021-05-07 US US17/314,158 patent/US20210330824A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017502946A5 (enExample) | ||
| AU2014396468B2 (en) | Modified cyclopentapeptides and uses thereof | |
| RU2145608C1 (ru) | Циклические пептиды, радиофармацевтический препарат, циклические пептиды, имеющие радиоактивную метку | |
| TWI583397B (zh) | 生產Ｆ－１８標記之Ａβ配位體之方法 | |
| CN112533937A (zh) | 用于结合cd38的肽配体 | |
| EP2560690A1 (en) | Cyclopentapeptide derivatives and uses thereof | |
| CN103889930B (zh) | 用于制备68Ga络合物的工艺 | |
| RU2013128360A (ru) | Her2-связывающие белки, меченые 18f-содержащим кремнийорганическим соединением | |
| CA3194483A1 (en) | Novel cxcr4-targeting compounds | |
| JP2019196356A (ja) | 精製方法及び組成物 | |
| JP2014500883A5 (enExample) | ||
| JP6231882B2 (ja) | 放射性コンジュゲーション方法 | |
| Mahmood et al. | 10. TECHNETIUM RADIOPHARMACEUTICALS | |
| WO2007122488A2 (en) | Radiofluorinated compounds and their preparation | |
| Kong et al. | Amino acid transporter-targeted radiotracers for molecular imaging in oncology | |
| EP3036208A1 (en) | Radiolabelling method | |
| US7919455B2 (en) | Marked peptides having affinity for a phospholipid and uses | |
| WO2013173630A1 (en) | Formulation of radiopharmaceuticals containing multiple acidic groups | |
| JP2012513980A5 (enExample) | ||
| Schutte | Novel radiopharmaceuticals: Characterization, substitution kinetics and biological evaluation of tricarbonyl complexes of rhenium (I) | |
| HK1027580A (en) | Radiolabeled platelet gpiib/iiia receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders | |
| Class et al. | Patent application title: CYCLOPENTAPEPTIDE DERIVATIVES AND USES THEREOF Inventors: Oliver Demmer (Muenchen, DE) Horst Kessler (Garching, DE) Horst Kessler (Garching, DE) Hans Jürgen Wester (Ilmmunster, DE) Hans Jürgen Wester (Ilmmunster, DE) Margret Schottelius (Muenchen, DE) Ingrid Dijkgraaf (Kranenburg, DE) Andreas Konard Buck (Muenchen, DE) Assignees: Technische Universität München Technische Universität München | |
| CN103167884A (zh) | 用干燥剂稳定放射性药物前体 |